In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical …

Posted on by

NEW YORK, Aug. 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] http://www.reportlinker.com/p01593771/In-Vitro-Diagnostic-IVD-Market-%5BInstruments-Reagents--Data-Management-Systems%5D-%5BTechnique-Immunoassay-Clinical-Chemistry-Molecular-Diagnostics-Haematology--Applications-Diabetes-Infectious-Diseases-Cancer--Cardiology%5D-Systems-End-Users%5D-.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] Forecast To 2017

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. The global in vitro disgnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Scope of the Report This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels.

Global IVD Market, by Technique: Immunochemistry Clinical Chemistry Molecular Diagnostics Hematology Microbiology Coagulation Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry)

Global IVD Market, by Product Type: Reagents Instruments Services Data Management System Software/Hardware

Global IVD Market, by Application: Diabetes Infectious Diseases Oncology Cardiology HIV/AIDS Autoimmune Diseases Drug Testing Nephrology Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications)

The rest is here:
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical ...

Stem Cell Therapy Treatment for Transverse Myelitis by Dr Alok Sharma, Mumbai, India. – Video

Posted on by


Stem Cell Therapy Treatment for Transverse Myelitis by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Transverse Myelitis by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: Objective...

By: Neurogen Brain and Spine Institute

Read the original:
Stem Cell Therapy Treatment for Transverse Myelitis by Dr Alok Sharma, Mumbai, India. - Video

PRC: Foreign docs doing stem cell therapy in PH must get special temporary permits

Posted on by

By: Jet Villa, InterAksyon.com August 6, 2013 4:34 PM

InterAksyon.com The online news portal of TV5

MANILA, Philippines - Amid a flurry of reports about unregulated procedures that have led to serious injury or even deaths, the Professional Regulation Commission (PRC) is now requiring foreign doctors wishing to practice stem cell therapy in the Philippines to obtain a special temporary permit (STP).

In a position statement, the Professional Regulatory Board of Medicine (PRBOM) said foreign doctors must submit proof of education, training and clinical experience and actual practice in the field of stem cell therapy, plus a current license to practice authenticated by the Philippine Embassy/Consulate in the country of origin when they apply for the special permits.

The board warned: Any foreign physician who practices the professionwithout a STP will be criminally liable for illegal practice of medicine.And, it added, those who have aided and abetted the foreign physicianspractice of the profession are also criminally liable.

The position paper was signed by PRBOM chairman Dr. Edgardo Fernando and members doctors Miguel Noche Jr., Florentino Doble, Restituto de Ocampo, Jose Cueto Jr., and Mildred Pareja.

Controversy hounds new group

The position statement on stem cell therapy was issued amid a growing rift among doctors over recent controversial cases, including several lawmakers who had procedures done, but whose conditions worsened.

One newly-founded group of doctors doing stem-cell transplant, the Philippine Society of Stem Cell Medicine (PSSCM), has been pitted by the controversy against the Philippine College of Physicians, Philippine Society of General Internal Medicine (PSGIM), Philippine Society of Hematology and Blood Transfusion (PSHBT) andPhilippine College of Chest Physicians (PCCP). The latter groups all believe thatPSSCM's practices are unethical as it charges huge fees from patients for stem cell procedures that are still under clinical trial.

The PRBOM has backed the Department of Health in issuing Administrative Order 2013-0012 providing the guidelines for stem cell, cell-based therapy in the country. "The practice of stem cell therapy does not constitute standard care at the present time. The claim that it offers cure to numerous diseases and conditions has not been proven through scientific research and documentation, the PRBOM said. Right now, it said, "there is difficulty verifying claims of practitioners and institutions regarding the effectivity ofavailable treatment modalities.

Read this article:
PRC: Foreign docs doing stem cell therapy in PH must get special temporary permits

Foreign doctors need permit for stem cell therapy

Posted on by

MANILA - Foreign doctors are now required to secure a permit to perform stem cell therapy in the country or face criminal liability.

The Professional Regulation Commission (PRC)s Board of Medicine (BOM) made the announcement yesterday, explaining that the requirement is part of government efforts to regulate the practice of stem cell therapy in the country to ensure the safety of patients.

In a statement, the BOM said foreign physicians who intend to practice stem cell therapy here must obtain special temporary permit from the PRC to avoid being charged with medical malpractice.

Even local doctors who have aided foreign physicians illegal practice of stem cell therapy shall be also held criminally liable, the BOM added.

To secure the special temporary permit, a foreign doctor must submit proof of education and actual practice in the field of stem cell therapy and current license authenticated by the Philippine embassy and the embassy in the country of origin.

The board said physicians should have acquired the necessary education, supervised training and extensive clinical experience prior to performing the treatment. It noted that the argument that stem cell therapy falls under the general practice of medicine since it only involves injection of stem cell solution is erroneous.

As professionals, physicians should be able to conduct self-assessment and self-evaluation regarding what they can and what they should not do, they added.

The BOM also noted that stem cell therapy should be practiced only in hospitals and clinics licensed by the Department of Heath for assurance that these medical facilities have the necessary manpower and equipment to prevent risks and hazards to patients.

The board also warned patients desiring to undergo stem cell therapy abroad to first verify the status of clinics and hospitals as well as practitioners from regulatory authorities.

Earlier, the Food and Drug Administration and the Philippine Medical Association (PMA) reported receiving numerous complaints of foreign doctors performing stem cell therapy in hotels and other non-medical facilities. The PMA said foreign doctors injected patients with animal-based stem cells at P1 million per shot, but these foreigners are not even licensed to practice medicine in the country.

More:
Foreign doctors need permit for stem cell therapy

From Harmless Colonizers to Virulent Pathogens: UB Microbiologists Identify What Triggers Disease

Posted on by

Newswise BUFFALO, N.Y. The bacteria Streptococcus pneumoniae harmlessly colonizes the mucous linings of throats and noses in most people, only becoming virulent when they leave those comfortable surroundings and enter the middle ears, lungs or bloodstream. Now, in research published in July in mBio, University at Buffalo researchers reveal how that happens.

We were asking, what is the mechanism behind what makes us sick? explains Anders P. Hakansson, PhD, assistant professor of microbiology and immunology in the UB School of Medicine and Biomedical Sciences. We are looking to find ways to interfere with the transition to disease. Few have looked at the specific mechanism that suddenly makes these bacteria leave the nose where they typically prefer to reside and travel into the lungs or the middle ear where they cause disease. If we can understand that process, then maybe we can block it.

Hakansson and his colleagues had previously found that when the pneumococci colonize the nose, they form sophisticated, highly structured biofilm communities.

In the current study, the research team grew biofilms of pneumococci on top of human epithelial cells, where the bacteria normally grow. They then infected these bacteria with influenza A virus or exposed them to the conditions that typically accompany the flu, including increased temperature to mimic fever, increased concentrations of ATP (the energy molecule in cells), and the stress hormone norepinephrine, released during flu infection. All three stimuli triggered a sudden release and departure of bacteria from the biofilm in the nose into otherwise normally sterile organs, such as the middle ears and lungs or into the bloodstream. At the same time, the researchers found that the gene expression profile of the bacteria that had dispersed from the biofilms revealed far more virulence.

Hakansson says the research demonstrates how the mammalian and bacterial kingdoms interact. Humans are the only natural hosts for these bacteria, he explains, when the viral infection comes in, there is this interkingdom signaling, where the bacteria respond to host molecules. If we can find ways to interrupt that signaling, we might be able to prevent disease.

Hakansson is affiliated with the Witebsky Center for Microbial Pathogenesis and Immunology and the New York State Center of Excellence in Bioinformatics and Life Sciences, both at UB. The major portion of the work was conducted by co-author Laura R. Marks, an MD/PhD candidate in the UB Department of Microbiology and Immunology, with co-authors Bruce A. Davidson, research assistant professor of anesthesiology and Paul R. Knight, III, MD, PhD, professor of anesthesiology and microbiology and immunology.

The work was funded by the UB Department of Microbiology and Immunology.

Follow this link:
From Harmless Colonizers to Virulent Pathogens: UB Microbiologists Identify What Triggers Disease

From harmless colonizers to virulent pathogens: Microbiologists identify what triggers disease

Posted on by

Aug. 6, 2013 The bacteria Streptococcus pneumoniae harmlessly colonizes the mucous linings of throats and noses in most people, only becoming virulent when they leave those comfortable surroundings and enter the middle ears, lungs or bloodstream. Now, in research published in July in mBio, University at Buffalo researchers reveal how that happens.

"We were asking, what is the mechanism behind what makes us sick?" explains Anders P. Hakansson, PhD, assistant professor of microbiology and immunology in the UB School of Medicine and Biomedical Sciences. "We are looking to find ways to interfere with the transition to disease. Few have looked at the specific mechanism that suddenly makes these bacteria leave the nose where they typically prefer to reside and travel into the lungs or the middle ear where they cause disease. If we can understand that process, then maybe we can block it."

Hakansson and his colleagues had previously found that when the pneumococci colonize the nose, they form sophisticated, highly structured biofilm communities.

In the current study, the research team grew biofilms of pneumococci on top of human epithelial cells, where the bacteria normally grow. They then infected these bacteria with influenza A virus or exposed them to the conditions that typically accompany the flu, including increased temperature to mimic fever, increased concentrations of ATP (the energy molecule in cells), and the stress hormone norepinephrine, released during flu infection. All three stimuli triggered a sudden release and departure of bacteria from the biofilm in the nose into otherwise normally sterile organs, such as the middle ears and lungs or into the bloodstream. At the same time, the researchers found that the gene expression profile of the bacteria that had dispersed from the biofilms revealed far more virulence.

Hakansson says the research demonstrates how the mammalian and bacterial kingdoms interact. "Humans are the only natural hosts for these bacteria," he explains, "when the viral infection comes in, there is this interkingdom signaling, where the bacteria respond to host molecules. If we can find ways to interrupt that signaling, we might be able to prevent disease."

Hakansson is affiliated with the Witebsky Center for Microbial Pathogenesis and Immunology and the New York State Center of Excellence in Bioinformatics and Life Sciences, both at UB. The major portion of the work was conducted by co-author Laura R. Marks, an MD/PhD candidate in the UB Department of Microbiology and Immunology, with co-authors Bruce A. Davidson, research assistant professor of anesthesiology and Paul R. Knight, III, MD, PhD, professor of anesthesiology and microbiology and immunology.

The work was funded by the UB Department of Microbiology and Immunology.

Excerpt from:
From harmless colonizers to virulent pathogens: Microbiologists identify what triggers disease

Medical Advancements in Genetic Engineering Journal OMICS Publishing Group – Video

Posted on by


Medical Advancements in Genetic Engineering Journal OMICS Publishing Group
This video belongs to Genetic Engineering which is a techinque of controlled manipulation of genes to change the genetic makeup of cells and move genes acros...

By: omicsgroupinc

See original here:
Medical Advancements in Genetic Engineering Journal OMICS Publishing Group - Video

Eastern medicine seeks to balance

Posted on by

By U-T San Diego Contributor 6 p.m.Aug. 6, 2013

Traditional Eastern medicine has been practiced the world over for thousands of years. These natural healing procedures have become increasingly popular for those seeking relief from physical and emotional ailments.

The main types of traditional Eastern medicine include acupuncture, moxibustion or heat therapy, herbal medicine, Chinese therapeutic massage, Tai Chi and lifestyle counseling.

Greg Lane, director of Clinical Services at Pacific College of Oriental Medicine in San Diego, said these complementary and alternative procedures are sometimes the first choice for patients searching for help on a wide variety of health issues.

The origins of traditional Eastern medicine date back to archaeological discoveries of stone needles thousands of years ago in the Neolithic era, Lane said. Since then, scholars and physicians have spent considerable time understanding and educating themselves and others on the foundations for the practices.

Advocates said the benefits of traditional Eastern medicine are plentiful, including pain relief. And many people report better sleep, less stress and a general feeling of peacefulness after experiencing an Eastern medicine modality, Lane said.

Many traditional medicines involve the use of natural substances.

Moxibustion, for example, involves the burning of the herb mugwort, and has been used to treat cancers. The American Cancer Society, while not endorsing its use, said a 2010 review of studies of moxibustion use during chemo suggested that it might help reduce the [associated] nausea and vomiting, but cautioned that the research methods were not rigorous enough to be certain.

Ayurveda is another traditional Eastern medicine that began in India. It includes using herbs, nutrition, acupressure massage and yoga. Ayurveda seeks to restore an individuals balance and harmony, contributing to a healthy, long life.

Ayurveda is based on three basic principles: diet, sleep and exercise. In Ayurveda, food is the No. 1 preventative medicine.

See original here:
Eastern medicine seeks to balance

Agein Corporation, a Leading Anti-Aging Company, Announces the Appointment of Dr. Richard M. Foxx as its Senior …

Posted on by

Boston, MA (PRWEB) August 07, 2013

Agein.com, the Internets premier anti-aging web site focusing on anti-aging tips, news, and advice from some of the foremost experts in the industry, is pleased to announce the appointment of Richard M. Foxx, MD as its Senior Medical Advisor.

We are very excited to have Dr. Foxx join Agein.com as the new Senior Medical Advisor, says Laura Foreman, the sites Anti-Aging Life Coach. His comprehensive background in anti-aging medicine, aesthetics, and wellness medicine breakthroughs makes Agein.com, in my opinion, the most comprehensive resource for anyone looking for the best anti-aging advice and information on the web.

Dr. Foxx has decades of medical experience, with a comprehensive background in endocrinology, aesthetic and laser medicine, gynecology, and sports medicine. He has extensive experience with professional athletes, including several Olympic competitors.

Dr. Foxx practices aesthetic and laser medicine, integrative medicine, and anti-aging medicine. He is the founder and Medical Director of The Medical and Skin Spa, located in Indian Wells, California, at the Hyatt Regency Resort.

Dr. Foxx is certified by the National Board of Medical Examiners and is a member of the American Academy of Anti-Aging Medicine, the American Academy of Aesthetic Medicine, and the International Academy of Cosmetic Dermatology, and a diplomat with the American Board of Obstetrics and Gynecology.

To learn more about Dr. Foxx and Agein Corporation, visit the companys web site at http://www.Agein.com.

About Agein.com: Agein.com's goal is to provide the latest anti-aging breakthroughs and advice in an easy-to-read format that gives readers the real, useful techniques to help maintain a youthful appearance. Agein.com's anti-aging experts specialize in diet, fitness, beauty and skin care, and how all of these areas affect the way people look and feel. Agein.com also provides information on all of the latest advances in anti-aging research, the hottest anti-aging trends in Hollywood, and beauty tips from Laura Foreman, Anti-Aging Life Coach.

Excerpt from:
Agein Corporation, a Leading Anti-Aging Company, Announces the Appointment of Dr. Richard M. Foxx as its Senior ...

LAB: FOOD MICROBIOLOGY – Video

Posted on by


LAB: FOOD MICROBIOLOGY
#3588; #3621; #3636; #3611; #3609; #3637; #3657; #3586; #3629; #3591; #3623; #3619; #3636; #3625; #3634; #3588; #3594; #3650; #3585; #3624; #3633; #3618; #3626; #3640; #3585; #3619; #3605; #3633; #3623; #3651; #3627; #3597; #3656; #3592; #3634; #3585; #3626; #3619; #3632; #3610; #3619; #3637;.

By: Varakorn Koschakosai

Read this article:
LAB: FOOD MICROBIOLOGY - Video